Skip to the page

Data / Form D filings / SunnyBay BioTech, Inc.

SunnyBay BioTech, Inc.: Form D filing

SunnyBay BioTech, Inc., a biotechnology company in Fremont, CA, filed a Form D with the SEC in 2023. The latest, on January 27, 2023, reports $2.2 million sold of a $6 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
46283 WARM SPRINGS BLVD., Fremont, CA, 94539
Phone
(512) 332-6968
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1963621

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 27, 2023New notice$5,980,914$2,230,915$3,749,9993Jan 11, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Feng Wang-JohanningExecutive Officer, Director
Xiangmin CuiDirector
Gary JohanningExecutive Officer
Peter ColabuonoDirector

Other biotechnology companies in California that filed recently

Every Form D from the week of Jan 23, 2023 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what SunnyBay BioTech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.